Search: onr:"swepub:oai:gup.ub.gu.se/313351" >
T2Candida Assay in ...
T2Candida Assay in the Diagnosis of Intraabdominal Candidiasis: A Prospective Multicenter Study
-
- Krifors, A. (author)
- Karolinska Institutet
-
- Ullberg, M. (author)
- Karolinska Institutet
-
- Castegren, M. (author)
- Karolinska Institutet
-
show more...
-
- Petersson, J. (author)
- Karolinska Institutet
-
- Sparrelid, E. (author)
- Karolinska Institutet
-
- Hammarström, Helena (author)
- Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för infektionssjukdomar,Institute of Biomedicine, Department of Infectious Medicine,Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Infect Dis, S-40234 Gothenburg, Sweden.;Sahlgrens Univ Hosp, Dept Infect Dis, Reg Vastra Gotaland, S-40234 Gothenburg, Sweden.
-
- Sjölin, Jan (author)
- Uppsala universitet,Infektionssjukdomar,Anestesiologi och intensivvård
-
- Oezenci, V. (author)
- Karolinska Institutet
-
- Blennow, O. (author)
- Karolinska Institutet
-
show less...
-
(creator_code:org_t)
- 2022-01-16
- 2022
- English.
-
In: Journal of Fungi. - : MDPI AG. - 2309-608X. ; 8:1
- Related links:
-
https://www.mdpi.com...
-
show more...
-
https://doi.org/10.3...
-
https://uu.diva-port... (primary) (Raw object)
-
https://gup.ub.gu.se...
-
https://doi.org/10.3...
-
https://urn.kb.se/re...
-
http://kipublication...
-
show less...
Abstract
Subject headings
Close
- The T2Candida magnetic resonance assay is a direct-from-blood pathogen detection assay that delivers a result within 3-5 h, targeting the most clinically relevant Candida species. Between February 2019 and March 2021, the study included consecutive patients aged >18 years admitted to an intensive care unit or surgical high-dependency unit due to gastrointestinal surgery or necrotizing pancreatitis and from whom diagnostic blood cultures were obtained. Blood samples were tested in parallel with T2Candida and 1,3-beta-D-glucan. Of 134 evaluable patients, 13 (10%) were classified as having proven intraabdominal candidiasis (IAC) according to the EORTC/MSG criteria. Two of the thirteen patients (15%) had concurrent candidemia. The sensitivity, specificity, positive predictive value, and negative predictive value, respectively, were 46%, 97%, 61%, and 94% for T2Candida and 85%, 83%, 36%, and 98% for 1,3-beta-D-glucan. All positive T2Candida results were consistent with the culture results at the species level, except for one case of dual infection. The performance of T2Candida was comparable with that of 1,3-beta-D-glucan for candidemic IAC but had a lower sensitivity for non-candidemic IAC (36% vs. 82%). In conclusion, T2Candida may be a valuable complement to 1,3-beta-D-glucan in the clinical management of high-risk surgical patients because of its rapid results and ease of use.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Mikrobiologi inom det medicinska området (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Microbiology in the medical area (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Infektionsmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Infectious Medicine (hsv//eng)
Keyword
- T2 magnetic resonance
- beta-glucan
- blood cultures
- intraabdominal
- candidiasis
- invasive candidiasis
- invasive candidiasis
- beta-glucan
- outcomes
- blood
- infections
- candidemia
- Microbiology
- Mycology
- T2 magnetic resonance
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database